Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans.

The efficacy and safety of oral LY217896 for prevention of experimental influenza A/Kawasaki/86 (H1N1) virus infection were assessed in susceptible males randomly assigned to receive LY217896 (75 mg) or placebo once daily for 7 days beginning 24 h prior to viral challenge. The rates of virus sheddin...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Hayden, F G, Tunkel, A R, Treanor, J J, Betts, R F, Allerheiligen, S, Harris, J
Format: Artigo
Sprog:Inglês
Udgivet: 1994
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC188174/
https://ncbi.nlm.nih.gov/pubmed/8067760
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker